An executive order signed on Tuesday, May 15, necessitated a change in plans for this panel discussion from the 2025 ...

May 1, 2025Kura Oncology, Inc. misses on earnings expectations. Reported EPS is $-0.66 EPS, expectations were $-0.51.

A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...

Community Oncology Conference, Nini Wu, MD, Navista, shares how AI can transform community oncology. The evolving role of ...

This road map to building a high-performance nursing team is a key component in health system’s efforts to expand cancer care ...

Fintel reports that on May 2, 2025, JP Morgan initiated coverage of CG Oncology (NasdaqGS:CGON) with a Overweight ...

Neal Shore, MD, FACS, discusses sasanlimab and its potential impact for community oncologists when treating patients with ...

Ann Foster's journey into nursing was inspired by her husband's cancer battle, leading her to pursue her childhood dream.

Thanks to budget cuts, many potential insights and treatments needed to propel oncology forward will never be realized.

Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corporation, is pleased to announce the extension ...

Pathos AI has launched a $400 million funding round and already raised nearly $283 million. The Chicago-based startup formed ...

The addition of chemotherapy to radiotherapy was not associated with improved survival among patients with intermediate-risk ...